Lauren H. Golden, MD, Appointed to New Position at NYU Langone Health

Dr Lauren H Golden

Endocrine Society member Lauren H. Golden, MD, a nationally renowned clinician, has been appointed director of the Center for Diabetes & Metabolic Health at NYU Langone Health to augment the institution’s efforts and reputation for excellence in diabetes care.

Golden is tasked with developing an acknowledged center of excellence in diabetes care by advancing care standards, building interdisciplinary clinical collaborations and broadening research efforts across NYU Langone’s multiple inpatient and outpatient sites. Golden also will work to increase access to care and diabetes education, preventive services and telehealth options to not only make patients’ lives easier, but also establish a more concrete infrastructure for the center.

Prior to joining NYU Langone, Golden served as an assistant professor of medicine and head of professional education at the Naomi Berrie Diabetes Center at Columbia University Medical Center.

“As a physician, it not only takes coordinated and multidisciplinary care to treat this chronic illness, but also takes collaboration with our patients to provide them with the best possible treatment plan and quality of life.”

“We’re excited to welcome Dr. Golden to NYU Langone,” says Ira J. Goldberg, MD, the Clarissa and Edgar Bronfman, Jr. Professor of Endocrinology and director of the Division of Endocrinology in the Department of Medicine at NYU Langone. “Her vast experience leading and bringing together comprehensive care teams will be invaluable to advancing our mission to advance diabetes care at our institution.”

After receiving her medical degree from the Mount Sinai Icahn School of Medicine, where she also completed her residency, Golden completed a clinical fellowship in endocrinology at the Yale School of Medicine and a fellowship in clinical investigation at Rockefeller University.

Her research and writing has been published in many peer-reviewed journals and textbooks including the American Journal of Pathology, EndoText, and Bone. Golden also has lectured at numerous professional society meetings.

“As a physician, it not only takes coordinated and multidisciplinary care to treat this chronic illness, but also takes collaboration with our patients to provide them with the best possible treatment plan and quality of life,” Golden says. “That’s why I’m thrilled to join an institution like NYU Langone that has seized the opportunity to advance care and access for its diabetes patients.”

You may also like

  • Webinar Will Examine Concerns Around Compounding Anti-Obesity Medications

    Endocrine Society to host virtual Science Writers Conference Nov. 14 Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications. Endocrine Society experts will discuss the importance of prescribing FDA-approved medications to treat obesity during the Society’s Virtual Science Writers Conference on November 14. What:…

  • Bianco Named Vice President and Vice Provost for Research, Chief Research Officer at UTMB

    Antonio Bianco, MD, PhD, has joined the University of Texas Medical Branch (UTMB) as vice president and vice provost, research, and chief research officer, effective Sept. 1. A renowned physician-scientist, scholar, and research leader, Bianco possesses an impressive academic career that includes influential contributions to the field of thyroid diseases and an enduring commitment to…

Find more in